West Pharmaceutical Services (WST) Change in Cash (2009 - 2026)

West Pharmaceutical Services has disclosed Change in Cash across 18 years of filings, most recently posting -$269.9 million for Q1 2026.

• Change in Cash for Q1 2026 came in at -$269.9 million, down 235.7% year-over-year; the trailing twelve-month figure through Mar 2026 was $117.2 million (up 159.31% YoY), and the FY2025 annual result was $306.7 million, up 183.05% from the prior year.
• Change in Cash came in at -$269.9 million for Q1 2026 at West Pharmaceutical Services, down from $162.8 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $165.3 million in Q4 2022 to a low of -$269.9 million in Q1 2026.
• The 5-year median for Change in Cash is -$6.3 million (2024), against an average of -$14.2 million.
• Across the five-year window, Change in Cash tumbled 3051.25% in 2024 and jumped 2684.13% in 2025, its largest moves.
• West Pharmaceutical Services' Change in Cash stood at $165.3 million in 2022, then slumped by 127.04% to -$44.7 million in 2023, then jumped by 85.91% to -$6.3 million in 2024, then surged by 2684.13% to $162.8 million in 2025, then sank by 265.79% to -$269.9 million in 2026.
• The last three Change in Cash figures came in at -$269.9 million (Q1 2026), $162.8 million (Q4 2025), and $118.8 million (Q3 2025), per Business Quant data.